- Home
- KROS vs BLDP Comparison
KROS vs BLDP Comparison
Compare KROS & BLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- BLDP
- Stock Information
- Founded
- KROS 2015
- BLDP 1979
- Country
- KROS United States
- BLDP Canada
- Employees
- KROS N/A
- BLDP N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- BLDP Industrial Machinery/Components
- Sector
- KROS Health Care
- BLDP Energy
- Exchange
- KROS Nasdaq
- BLDP Nasdaq
- Market Cap
- KROS 558.9M
- BLDP 479.7M
- IPO Year
- KROS 2020
- BLDP 1995
- Fundamental
- Price
- KROS $13.37
- BLDP $1.61
- Analyst Decision
- KROS Buy
- BLDP Sell
- Analyst Count
- KROS 13
- BLDP 11
- Target Price
- KROS $20.63
- BLDP $1.71
- AVG Volume (30 Days)
- KROS 637.6K
- BLDP 10.2M
- Earning Date
- KROS 08-06-2025
- BLDP 08-11-2025
- Dividend Yield
- KROS N/A
- BLDP N/A
- EPS Growth
- KROS N/A
- BLDP N/A
- EPS
- KROS 0.11
- BLDP N/A
- Revenue
- KROS $214,713,000.00
- BLDP $70,668,000.00
- Revenue This Year
- KROS $5,006.76
- BLDP $43.80
- Revenue Next Year
- KROS N/A
- BLDP $25.81
- P/E Ratio
- KROS $123.16
- BLDP N/A
- Revenue Growth
- KROS 91657.70
- BLDP N/A
- 52 Week Low
- KROS $9.12
- BLDP $1.00
- 52 Week High
- KROS $72.37
- BLDP $2.71
- Technical
- Relative Strength Index (RSI)
- KROS 42.27
- BLDP 53.90
- Support Level
- KROS $13.25
- BLDP $1.39
- Resistance Level
- KROS $13.99
- BLDP $1.64
- Average True Range (ATR)
- KROS 0.36
- BLDP 0.11
- MACD
- KROS -0.06
- BLDP -0.01
- Stochastic Oscillator
- KROS 20.75
- BLDP 40.59
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About BLDP Ballard Power Systems Inc.
Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from Poland followed by United States, United Kingdom, and other countries.